Skip to main content

Table 1 Clinical and biochemical characteristics of the study population

From: Pleiotropic association of LIPC variants with lipid and urinary 8-hydroxy deoxyguanosine levels in a Taiwanese population

 

Total

Men

Women

P value

Number

572

296

276

 

Age (years)

45.7 ± 9.7

45.0 ± 9.6

46.5 ± 9.7

0.076

BMI (kg/m2)

24.2 ± 3.4

24.9 ± 3.0

23.5 ± 3.6

< 0.001

Fasting plasma glucose (mg/dL)

92.0 (88.0, 98.0)

94.0 (89.0, 100.0)

90.5 (86.0, 96.0)

< 0.001

Fasting serum insulin (μU/mL)

7.8 (6.1, 10.6)

8.3 (6.4, 11.4)

7.5 (5.9, 10.3)

0.01

HOMAIR

1.8 (1.4, 2.5)

2.0 (1.5, 2.6)

1.7 (1.3, 2.4)

< 0.001

Waist circumference (cm)

84.8 ± 9.4

87.7 ± 7.4

81.7 ± 10.3

< 0.001

Waist hip ratio

0.9 ± 0.1

0.9 ± 0.0

0.8 ± 0.1

< 0.001

Current smokers (%)

19.4

33.8

4.0

< 0.001

Hypertension (%)

8.9

8.0

9.8

0.309

Diabetes mellitus (%)

3.3

4.1

2.5

0.312

Total cholesterol (mg/dL)

199.3 ± 35.9

201.6 ± 35.8

196.8 ± 36.0

0.089

LDL-C (mg/dL)

116.5 ± 32.9

119.4 ± 33.7

113.5 ± 31.8

0.036

HDL-C (mg/dL)

54.0 (45.0, 65.0)

48.0 (42.0, 55.0)

61.0 (51.3, 71.0)

< 0.001

TG (mg/dL)

114.5 (76.0, 164.8)

135.0 (92.0, 203.8)

91.0 (67.0, 134.8)

< 0.001

CRP (mg/L)

0.6 (0.3, 1.2)

0.6 (0.3, 1.2)

0.5 (0.2, 1.2)

0.098

Fibrinogen (mg/dL)

260.3 ± 67.3

256.9 ± 68.8

263.8 ± 65.6

0.187

sE-selectin(ng/L)

49.9 (35.6, 64.3)

57.0 (41.6, 73.5)

42.5 (31.1, 54.7)

< 0.001

sP-selectin(ng/mL)

95.0 (65.9, 169.7)

103.9 (70.0, 187.8)

86.7 (60.0, 151.3)

0.005

SAA (μmol/L)

3.6 (1.7, 6.0)

3.3 (1.6, 6.0)

3.6 (1.7, 6.1)

0.399

sICAM1 (ng/L)

228.0 (179.9, 275.1)

232.0 (182.0, 283.6)

225.1 (175.8, 271.6)

0.776

sVCAM1(ng/L)

477.0 (406.0, 545.0)

479.0 (399.0, 555.0)

476.0 (415.0, 540.0)

0.81

MMP-1 (pg/mL)

188.3 (102.1, 398.8)

184.8 (110.8, 404.4)

189.0 (96.2, 398.4)

0.601

MMP-2 (ng/mL)

122.2 (103.1, 140.4)

118.9 (98.7, 137.5)

124.9 (106.9, 146.1)

0.018

MMP-9 (mg/L)

109.9 (73.8, 167.3)

120.5 (83.3, 184.6)

99.4 (66.1, 150.2)

0.003

MCP-1 (pg/mL)

59.8 (43.6, 83.5)

62.6 (46.1, 86.7)

56.2 (40.9, 80.8)

0.005

sTNFRII (pg/mL)

3095.8 (2635.9, 3708.9)

3120.2 (2742.4, 3726.3)

3066.8 (2528.2, 3700.6)

0.018

8-OHdG/creatinine (ng/mg)

32.6 (24.3, 44.2)

30.4 (22.5, 40.0)

35.2 (26.8, 48.4)

< 0.001

LIPC-rs2043085

    

 CC

159 (28.3%)

73 (25.2%)

86 (31.6%)

0.198

 TC

284 (50.5%)

150 (51.7%)

134 (49.3%)

 

 TT

119 (21.2%)

67 (23.1%)

52 (19.1%)

 

LIPC-rs1532085

    

 GG

162 (28.8%)

74 (25.5%)

88 (32.2%)

0.200

 GA

287 (51.0%)

153 (52.8%)

134 (49.1%)

 

 AA

114 (20.2%)

63 (21.7%)

51 (18.7%)

 

LIPC-rs1800588

    

 CC

228 (40.5%)

125 (43.1%)

103 (37.7%)

0.659

 TC

261 (46.4%)

128 (44.1%)

133 (48.7%)

 

 TT

74 (13.1%)

37 (12.8%)

37 (13.6%)

 
  1. BMI body mass index, HOMA-IR homeostasis model assessment of insulin resistance, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TG Triglycerides, CRP C-reactive protein, sE-selectin soluble E-selectin, sP-selectin soluble P-selectin, SAA serum amyloid A, sICAM1 soluble intercellular adhesive molecule 1, sVCAM1 soluble vascular cell adhesive molecule 1, MMP1 matrix metalloproteinase 1, MMP2 matrix metalloproteinase 2, MMP9 matrix metalloproteinase 9, MCP-1 Monocyte chemotactic protein-1, sTNFRII soluble tumor necrosis factor-alpha receptor 2, 8-OHdG 8-hydroxy deoxyguanosine. Continuous variables are presented as mean ± SD. Fasting plasma glucose, fasting serum insulin, HOMAIR, HDL-C, TG, CRP, sE-selectin, sP-selectin, SAA, sICAM1, sVCAM1, MMP1, MMP2, MMP9, MCP1, sTNFRII and 8-OHdG values were logarithmically transformed before statistical testing to meet the assumption of normal distributions; however, the untransformed data are shown as median (range)
  2. All variables had non-normal distributions after Normality test, including fasting plasma glucose, fasting serum insulin, HOMAIR, sE-selectin, sP-selectin, SAA, sICAM1, MMP1, MMP2, MMP9, MCP1 and sTNFRII were analyzed by using Kolmogorov-Smirnov test